{
  "ticker": "RARE",
  "success": true,
  "price": {
    "current": 24.27,
    "currency": "USD",
    "day_high": 24.69,
    "day_low": 23.99,
    "52_week_high": 46.5,
    "52_week_low": 18.41
  },
  "market_cap": {
    "value": 2341510656.0,
    "currency": "USD"
  },
  "shares_outstanding": 96477569.0,
  "volume": {
    "last": 1579841,
    "average_30d": 3251019
  },
  "valuation": {
    "pe_ratio": null,
    "forward_pe": -5.68263,
    "price_to_book": 255.4737
  },
  "company_info": {
    "name": "Ultragenyx Pharmaceutical Inc.",
    "sector": "Healthcare",
    "industry": "Biotechnology"
  },
  "balance_sheet": {
    "success": true,
    "period_date": "2025-09-30",
    "total_assets": 1190445000.0,
    "total_liabilities": 1174286000.0,
    "stockholders_equity": 9159000.0,
    "cash": 202510000.0,
    "marketable_securities": 222738000.0,
    "total_liquidity": 425248000.0,
    "total_debt": 33833000.0,
    "long_term_debt": 21691000.0,
    "current_debt": 12142000.0,
    "error": null
  },
  "cash_flow": {
    "success": true,
    "period_date": "2025-09-30",
    "operating_cash_flow": -91423000.0,
    "free_cash_flow": -92701000.0,
    "investing_cash_flow": 117182000.0,
    "financing_cash_flow": 2000.0,
    "error": null
  },
  "income_statement": {
    "success": true,
    "period_date": "2025-09-30",
    "operating_expense": 302832000.0,
    "research_and_development": 216212000.0,
    "interest_expense": 14148000.0,
    "net_income": -180413000.0,
    "revenue": 159933000.0,
    "gross_profit": 131942000.0,
    "ebitda": -156786000.0,
    "error": null
  },
  "data_quality": {
    "flags": [],
    "has_price": true,
    "has_market_cap": true,
    "has_volume": true,
    "has_balance_sheet": true,
    "has_cash_flow": true,
    "has_income_statement": true
  },
  "provenance": {
    "source": "Yahoo Finance via yfinance",
    "timestamp": "2026-01-29T16:51:02.968026",
    "url": "https://finance.yahoo.com/quote/RARE",
    "data_hash": "df77c1c771a5f17c"
  }
}